title: Severe leucopenia associated with Sitagliptin use.
authors.affiliation: Department of Internal Medicine, Diabetes Care Unit, Catholic University School of Medicine, Rome, Italy. dario.pitocco@rm.unicatt.it
authors.forename: Dario
authors.initials: D
authors.lastname: Pitocco
authors.forename: Francesco
authors.initials: F
authors.lastname: Zaccardi
authors.forename: Francesca
authors.initials: F
authors.lastname: Martini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Scavone
authors.forename: Tittania
authors.initials: T
authors.lastname: Musella
authors.forename: Salvatore
authors.initials: S
authors.lastname: Caputo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Ghirlanda
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced* / Q000175:diagnosis*; D008297:Male; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D011719:Pyrazines; D014230:Triazoles; D000068900:Sitagliptin Phosphate